US · Healthcare

Lobe Sciences Ltd (LOBEF)

Biotechnology

Lobe Sciences Ltd (LOBEF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for LOBEF

P/E ratio

18.00

Lobe Sciences Ltd (LOBEF) — FAQ

What is LOBEF's P/E ratio?

The price-to-earnings (P/E) ratio for Lobe Sciences Ltd (LOBEF) is 18.00 (data as of 2026-03-24).

Does Lobe Sciences Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Lobe Sciences Ltd (LOBEF). Check the MyAverix Finance app for the latest dividend data.

What sector is Lobe Sciences Ltd in?

Lobe Sciences Ltd (LOBEF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is LOBEF listed on?

LOBEF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)